Lennox-Gastaut – debating the boundaries of diagnosis Chair: Richard Chin, UK Use of narrow diagnostic criteria for a meaningful diagnosis of LGS: Andreas Schulze-Bonhage, Germany
The merits of a broader definition of LGS: Selim Benbadis, USA
Q&A
Sponsored by GW Pharmaceuticals
Friday, October 30, 2020 | 15:00-15:50 (CET)
Treatment goals should always focus on continuous dopaminergic stimulation Moderator: Stuart Isaacson, USA
Early as possible: Laxman Bahroo, USA Once fluctuations emerge: Fernando Pagan, USA Discussion and Rebuttals
Supported by Amneal
Friday, October 30, 2020 | 15:55-16:45 (CET)
Navigating the treatment options for “OFF" Episodes in Parkinson’s disease: The role of on-demand treatments Moderator: Stuart Isaacson, USA
Should use after adjunctive therapies: Rajesh Pahwa, USA Should be used early: Fernando Pagan, USA Discussion and Rebuttals
Supported by Sunovion
Friday, October 30, 2020 | 16:50-17:40 (CET)
Clinical approach to treat OFF periods when symptoms return Moderator: Stuart Isaacson, USA
Who and when: Jill Farmer, USA Which and why: Yasar Torres-Yaghi, USA Discussion and Rebuttals
Supported by Acorda
Friday, October 30, 2020 | 17:45-18:35 (CET)
Why do people with PD fall? Moderator: Stuart Isaacson, USA
Panel: Rajesh Pahwa, USA, Aristide Merola, USA, Thurmon Lockhart, USA Discussion and Rebuttals
Supported by Lundbeck
Friday, October 30, 2020 | 18:40-19:30 (CET)
Dementia related psychosis: Should cognition or psychosis be prioritized? Moderators: Stuart Isaacson, USA; Richard Jackson, USA
Psychosis: Daniel Kremens, USA Cognition: Yasar Torres-Yaghi, USA Discussion and Rebuttals
Supported by Acadia
Friday, October 30, 2020 | 19:35-20:25 (CET)
Recognizing and assessing impact of tardive dyskinesia Moderators: Stuart Isaacson, USA; Laxman Bahroo, USA
Recognition: Fiona Gupta, USA Impact: Richard Jackson, USA Discussion and Rebuttals